ISPE looking at drug shortages globally; Albemarle puts $30M in plant expansion;

> Contract manufacturer Aesica has teamed with EmulTech to develop a new emulsion technology that can be used on a variety of APIs, particularly for depot injections for sustained release. Release

> ISPE, the International Society for Pharmaceutical Engineering, is conducting a global survey on drug shortages that will be sent to its international membership later this month. Item

> The FDA is looking at manufacturing issues at CryoLife ($CRY). Item

> Albemarle Fine Chemistry Services will invest another $30 million in its plant in Tyrone, PA. Item

> Spain-based engineering company Telstar has started a Quality by Design (QbD) services arm. Item